Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression

Journal of Immunology

Volumn 165, Issue 11, 2000, Pages 6576-6582

  Baranzini, S E ^a   Elfstrom, C ^a   Chang, S Y ^a   Butunoi, C ^a   Murray, R ^a   Higuchi, R ^a   Oksenberg, J R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR; CYTOKINE; HLA DR ANTIGEN; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN BASIC PROTEIN; RANTES; TRANSFORMING GROWTH FACTOR ALPHA;

ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATION; EXTRAVASATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; TRANSCRIPTION INITIATION;

EID: 0034548707     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.11.6576     Document Type: Article

References (36)

1. Multiple sclerosis: A polygenic disease involving epistatic interactions, germline rearrangements and environmental effects
2. Emerging concepts of pathogenesis: Relationship to multiple sclerosis therapies
3. Demyelinating diseases
4. Multiple sclerosis: Lessons from neuropathology
5. The adhesion molecule and cytokine profile of multiple sclerosis lesions
6. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
7. + T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions
8. Expression of transforming growth factor (TGF)-β1, -β2, and -β3 isoforms and TGF-β type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures
9. IL-15 mRNA expression is up-regulated in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis (MS)
10. Association of interleukin-1β and interleukin-1 receptor antagonist genes with disease severity in MS
11. Shedding of TNF receptors in multiple sclerosis patients
12. Balancing the Th1/Th2 concept in multiple sclerosis
13. Analysis of a sequenced cDNA library from multiple sclerosis lesions
14. Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays
15. The role of TNFα and lymphotoxin in demyelinating disease
16. Kinetic PCR analysis: Real-time monitoring of DNA amplification reactions
17. Transcript quantitation in total yeast cellular RNA using kinetic PCR
18. Transcript imaging of the development of human T helper cells using oligonucleotide arrays
19. On classification of post-mortem multiple sclerosis plaques for neuroscientists
20. Amplification of RNA, high temperature reverse transcription and DNA amplification with Thermus thermophilus DNA polymerase
21. No adjustments are needed for multiple comparisons
22. Cluster analysis and display of genome-wide expression patterns
23. Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis
24. 1 mice with acute experimental allergic encephalomyelitis induced with two different synthetic peptides of myelin proteolipid protein
25. Immune-mediated encephalitis: On the role of antigen-presenting cells in brain tissue
26. Retinal microglia differentially express phenotypic markers of antigen-presenting cells in vitro
27. Expression of only one myelin basic protein allele in mouse is compatible with normal myelination
28. Myelin gene expression during demyelination and remyelination in aggregating brain cell cultures
29. Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus)
30. Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis
31. B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions
32. Identification of autoantibodies associated with myelin damage in multiple sclerosis
33. Multiple sclerosis: An autoimmune disease of multifactorial etiology
34. Multiple sclerosis brain immunoglobulins stimulate myelin basic protein degradation in human myelin: A new cause of demyelination
35. Immunoglobulins promote remyelination in the central nervous system
36. Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis